Cargando…

Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller

Detalles Bibliográficos
Autores principales: Leitman, Ellen M., Willberg, Christian B., De Burgh-Thomas, Andrew, Streeck, Hendrik, Goulder, Philip J.R., Matthews, Philippa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788062/
https://www.ncbi.nlm.nih.gov/pubmed/26959357
http://dx.doi.org/10.1097/QAD.0000000000001022
_version_ 1782420700695363584
author Leitman, Ellen M.
Willberg, Christian B.
De Burgh-Thomas, Andrew
Streeck, Hendrik
Goulder, Philip J.R.
Matthews, Philippa C.
author_facet Leitman, Ellen M.
Willberg, Christian B.
De Burgh-Thomas, Andrew
Streeck, Hendrik
Goulder, Philip J.R.
Matthews, Philippa C.
author_sort Leitman, Ellen M.
collection PubMed
description
format Online
Article
Text
id pubmed-4788062
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-47880622016-04-05 Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller Leitman, Ellen M. Willberg, Christian B. De Burgh-Thomas, Andrew Streeck, Hendrik Goulder, Philip J.R. Matthews, Philippa C. AIDS Correspondence Lippincott Williams & Wilkins 2016-03-27 2016-03-07 /pmc/articles/PMC4788062/ /pubmed/26959357 http://dx.doi.org/10.1097/QAD.0000000000001022 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Correspondence
Leitman, Ellen M.
Willberg, Christian B.
De Burgh-Thomas, Andrew
Streeck, Hendrik
Goulder, Philip J.R.
Matthews, Philippa C.
Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
title Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
title_full Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
title_fullStr Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
title_full_unstemmed Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
title_short Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
title_sort subdominant gag-specific anti-hiv efficacy in an hla-b(∗)57-positive elite controller
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788062/
https://www.ncbi.nlm.nih.gov/pubmed/26959357
http://dx.doi.org/10.1097/QAD.0000000000001022
work_keys_str_mv AT leitmanellenm subdominantgagspecificantihivefficacyinanhlab57positiveelitecontroller
AT willbergchristianb subdominantgagspecificantihivefficacyinanhlab57positiveelitecontroller
AT deburghthomasandrew subdominantgagspecificantihivefficacyinanhlab57positiveelitecontroller
AT streeckhendrik subdominantgagspecificantihivefficacyinanhlab57positiveelitecontroller
AT goulderphilipjr subdominantgagspecificantihivefficacyinanhlab57positiveelitecontroller
AT matthewsphilippac subdominantgagspecificantihivefficacyinanhlab57positiveelitecontroller